2012非ST段抬高急性冠状动脉综合征诊断和治疗指南.doc

万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据非ST段抬高急性冠状动脉综合征诊断和治疗指南作者： 中华医学会心血管病学分会， 中华心血管病杂志编辑委员会作者单位：刊名： 中华心血管病杂志英文刊名： Chinese Journal of Cardiology年，卷(期)： 2012,40(5)参考文献(98条)1.Laskey WK;Jenkins C;Selzer F Volume-to-creatinine clearance ratio:a pharmacokinetically based riskfactor for prediction of early creatinine increese after percutaneous coronary intervention 20072.Pannu N;Wiebe N;Tonelli M Prophylaxis strategies for contrast-induced nephropathy 20063.Collet JP;Montalescot G;Agnelli G Non-ST-segment elevation acute coronary syndrome in patientswith renal dysfunction:benefit of low-molecular-weight heparin alone or with glycoprotein b/a inhibitors on outcomes.The global registry of acute coronary events 20054.Stone GW;Kedhi E;Kereiakes DJ Differential clinical responses to everolimus-eluting andpaclitaxel-eluting coronary stents in patients with and without diabetes mellitus 20115.Chaitman BR;Hardison RM;Adler D The bypass angioplasty revascularization investigation 2 diabetesrandomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemicheart disease:impact of treatment strategy on cardiac mortality and myocardial infarction 20096.Szummer K;Lundman P;Jacobson SH Influence of renal function on the effects of earlyrevascularization in non-ST-elevation myocardial infarction:data from the Swedish web-system forenhancement and development of evidence-based care in heart disease evaluated according torecommended therapies (SWEDEHEART) 20097.Mehta SR;Cannon CP;Fox KA Routine vs selective invasive strategies in patients with acute coronarysyndromes:a collaborative meta-analysis of randomized trials 20058.Alexander KP;Newby LK;Cannon CP Acute coronary care in the elderly,part :non-ST-segment-elevation acute coronary syndromes:a scientific statement for healthcare professionals from theAmerican Heart Association Council on Clinical Cardiology:in collaboration with the Society ofGeriatric Cardiology 20079.Menzin J;Wygant G;Hauch O One-year costs of ischemic heart disease among patients with acutecoronary syndromes:findings from a multi-employer claims database 200810.Moss AJ;Zareba W;Hall WJ Prophylactic implantation of a defibrillator in patients with myocardialinfarction and reduced ejection fraction 200211.Dickstein K;Vardas PE;Auricchio A 2010 focused update of ESC guidelines on device therapy inheart failure:an update of the 2008 ESC guidelines for the diagnosis and treatment of acute andchronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy.Developed with the special contribution of the Heart Failure Association and the European HeartRhythm Association 201012.Steg PG;Dabbous OH;Feldman LJ Determinants and prognostic impact of heart failure complicatingacute coronary syndromes:observations from the global registry of acute coronary events (GRACE) 200413.Norhammar A;Malmberg K;Diderholm E Diabetes mellitus:the major risk factor in unstable coronaryartery disease even after consideration of the extent of coronary artery disease and benefits ofrevascularization 200414.Anderson JL;Adams CD;Antman EM ACC/AHA 2007 guidelines for the management of patients withunstable angina/non ST elevation myocardial infarction:a report of the American College ofCardiology/American Heart Association task force on practice guidelines (writing committee to revisethe 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardialinfarction) 200715.NICE-SUGAR study investigators;Finfer S;Chittock DR;Su SY Intensive versus conventional glucosecontrol in critically ill patients 200916.De Caterina R;Madonna R;Sourij H Glycaemic control in acute coronary syndromes:prognostic valueand therapeutic options 201017.Berger JS;Elliott L;Gallup D Sex differences in mortality following acute coronary syndromes 200918.Bassand JP;Afzal R;Eikelboom J Relationship between baseline hemoglobin and major bleedingcomplications in acute coronary syndromes 201019.Steg PG;Huber K;Andreotti F Bleeding in acute coronary syndromes and percutaneous coronaryinterventions:position paper by the working group on thrombosis of the European Society ofCardiology 201120.Hicks KA;Stockbridge NL;Targum SL Bleeding academic research consortium consensus report:thefood and drug administration perspective 201121.Mehran R;Rao SV;Bhatt DL Standardized bleeding definitions for cardiovascular clinical trials:aconsensus report from the bleeding academic research consortium 201122.Valgimigli M;Dawkins K;Macaya C Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-elutingstents:a subanalysis of the ARTS trial 200723.Parikh SV;de Lemos JA;Jessen ME Timing of in-hospital coronary artery bypass graft surgery fornon-ST-segment elevation myocardial infarction patients:results from the nationalcardiovascular data registry ACTION Registry-GWTG (acute coronary treatment and interventionoutcomes network registry-get with the guidelines) 201024.Schmitt J;Duray G;Gersh BJ Atrial fibrillation in acute myocardial infarction:a systematic reviewof the incidence,clinical features and prognostic implications 200925.Zipes DP;Camm AJ;Borggrefe M ACC/AHA/ESC 2006 guidelines for management of patients withventricular arrhythmias and the prevention of sudden cardiac death-executive summary:a report of theAmerican College of Cardiology/American Heart Association task force and the European Society ofCardiology Committee for practice guidelines (writing committee to develop guidelines for managementof patients with ventricular arrhythmias 200626.Hill SR;Carless PA;Henry DA Transfusion thresholds and other strategies for guiding allogeneicred blood cell transfusion 200227.Katritsis DG;Siontis GC;Kastrati A Optimal timing of coronary angiography and potentialintervention in non-ST-elevation acute coronary syndromes 201028.Sorajja P;Gersh BJ;Cox DA Impact of delay to angioplasty in patients with acute coronarysyndromes undergoing invasive management:analysis from the ACUITY (acute catheterization andurgent intervention triage strategy) trial 201029.Montalescot G;Cayla G;Collet JP Immediate vs delayed intervention for acute coronary syndromes:arandomized clinical trial 200930.Mehta SR;Granger CB;Boden WE Early versus delayed invasive intervention in acute coronarysyndrome 200931.Hillis LD;Smith PK;Anderson JL 2011 ACCF/AHA guideline for coronary artery bypass graft surgery.Areport of the American College of Cardiology Foundation/American Heart Association task force onpractice guidelines. Developed in collaboration with the American Association for ThoracicSurgery,Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons 201132.Libby P;Bonow RO Braunwalds Heart Disease 200833.Fraker TD Jr;Fihn SD;Gibbons RJ 2007 Chronic angina focused update of the ACC/AHA 2002 guidelinesfor the management of patients with chronic stable angina:a report of the American College ofCardiology/American Heart Association task force on practice guidelines writing group to develop thefocused update of the 2002 guidelines for the management of patients with chronic stable angina 200734.European Heart Rhythm Association;European Association for Cardio-Thoracic Surgery;Camm AJGuidelines for the management of atrial fibrillation:the task force for the management of atrialfibrillation of the European Society of Cardiology (ESC) 201035.Kaiser C;Galatius S;Erne P Drug-eluting versus baremetal stents in large coronary arteries 201036.Serruys PW;Morice MC;Kappetein AP Percutaneous coronary intervention versus coronary arterybypass grafting for severe coronary artery disease 200937.Jiang M;He B;Zhang Q Timing of early invasive intervention in patients with moderate to high riskacute coronary syndromes 201238.Damman P;Hirsch A;Windhausen F 5-year clinical outcomes in the ICTUS (invasive versusconservative treatment in unstable coronary syndromes) trial a randomized comparison of an earlyinvasive versus selective invasive management in patients with non-ST-segment elevation acutecoronary syndrome 201039.Sever PS;Poulter NR;Dahl(o)f B Different time course for prevention of coronary and stroke eventsby atorvastatin in the Anglo-Scandinavian cardiac outcomes trial-lipid-lowering arm (ASCOT-LLA) 200540.Patti G;Chello M;Gatto L Short-term atorvastatin preload reduces levels of adhesion molecules inpatients with acute coronary syndrome undergoing percutaneous coronary intervention.Results from theARMYDA-ACS CAMs (atorvastatin for reduction of myocardial damage during angioplasty-cell adhesionmolecules)substudy 201041.Di Sciascio G;Patti G;Pasceri V Efficacy of atorvastatin reload in patients on chronicstatin therapy undergoing percutaneous coronary intervention:results of the ARMYDARECAPTURE(atorvastatin for reduction of myocardial damage during angioplasty) randomized trial 200942.Patti G;Pasceri V;Colonna G Atorvastatin pretreatment improves outcomes in patients with acutecoronary syndromes undergoing early percutaneous coronary intervention:results of the ARMYDA-ACSrandomized trial 200743.Pasceri V;Patti G;Nusca A Randomized trial of atorvastatin for reduction of myocardial damageduring coronary intervention:results from the ARMYDA (atorvastatin for reduction of myocardialdamage during angioplasty) study 200444.ODonoghue M;Boden WE;Braunwald E Early invasive vs conservative treatment strategies in womenand men with unstable angina and non-ST-segment elevation myocardial infarction:a meta-analysis 200845.Greenhalgh J;Hockenhull J;Rao N Drug-eluting stents versus bare metal stents for angina or acutecoronary syndromes 201046.中华医学会心血管病学分会;中华心血管病杂志编辑委员会 急性ST段抬高型心肌梗死诊断与治疗指南 201047.Levine GN;Bates ER;Blankenship JC 2011 ACCF/AHA/SCAI guideline for percutaneous coronaryintervention.A report of the American College of Cardiology Foundation/American Heart Associationtask force on practice guidelines and the society for cardiovascular angiography and interventions201148.中华医学会心血管病分会介入心脏病学组;中华心血管病杂志编辑委员会 中国经皮冠状动脉介入治疗指南2012(简本) 201249.Task force on myocardial revascularization of the European Society of Cardiology (ESC) and theEuropean Association for Cardio-Thoracic Surgery (EACTS);European Association for PercutaneousCardiovascular Interventions (EAPCI);Wijns W Guidelines on myocardial revascularization 201050.Hulten E;Jackson JL;Douglas K The effect of early,intensive statin therapy on acute coronarysyndrome:a meta-analysis of randomized controlled trials 200651.Hirsh J;Raschke R Heparin and low-molecular-weight heparin:the seventh ACCP conference onantithrombotic and thrombolytic therapy 200452.Cohen M;Demers C;Gurfinkel EP A comparison of low-molecular-weight heparin with unfractionatedheparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group 199753.Stone GW;White HD;Ohman EM Acute catheterization and urgent intervention triage strategy(ACUITY) trial investigators.Bivalirudin in patients with acute coronary syndromes undergoingpercutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgentintervention triage strategy (ACUITY) trial 200754.Stone GW;Mclaurin BT;Cox DA Bivalirudin for patients with acute coronary syndromes 200655.Petersen JL;Mahaffey KW;Hasselblad V Efficacy and bleeding complications among patientsrandomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segmentelevation acute coronary syndromes:a systematic overview 200456.中华医学会心血管病学分会;中华心血管病杂志编辑委员会 不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南 200757.Briguori C;Visconti G;Focaccio A Novel approaches for preventing or limiting events (Naples) trial:impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction200958.Sabatine MS;Antman EM;Widimsky P Otamixaban for the treatment of patients with non-ST-elevationacute coronary syndromes (SEPIA-ACS1 TIMI42):a randomized,double-blind,active-controlled,phase 2trial 200959.Mega JL;Braunwald E;Mohanavelu S Rivaroxaban versus placebo in patients with acute coronarysyndromes (ATLAS ACS-TIMI 46):a randomized,double-blind,phase trial 200960.APPRAISE steering committee and investigators;Alexander JH;Becker RC Apixaban,anoral,direct,selective factor Xa inhibitor,in combination with antiplatelet therapy after acutecoronary syndrome:results of the apixaban for prevention of acute ischemic and safety events(APPRAISE) trial 200961.Lip GY;Huber K;Andreotti F Antithrombotic management of atrial fibrillation patients presentingwith acute coronary syndrome and/or undergoing coronary stenting:executive summary-a consensusdocument of the European Society of Cardiology working group on thrombosis,endorsed by the EuropeanHeart Rhythm Association (EHRA) and the European Association of Percutaneous CardiovascularInterventions (EAPCI) 201062.Stone GW;Bertrand ME;Moses JW Routine upstream initiation vs deferred selective use ofglycoprotein b/ a inhibitors in acute coronary syndromes:the ACUITY timing trial 200763.Neumann FJ;Kastrati A;Pogatsa-Murray G Evaluation of prolonged antithrombotic pretreatment(cooling-off strategy)before intervention in patients with unstable coronary syndromes:arandomized controlled trial 200364.Hamm CW;Bassand JP;Agewall S ESC guidelines for the management of acute coronary syndromes inpatients presenting without persistent ST-segment elevation:the task force for the management ofacute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of theEuropean Society of Cardiology (ESC) 201165.FUTURA/OASIS-8 trial group;Steg PG;Jolly SS Low-dose vs standard-dose unfractionated heparin forpercutaneous coronary intervention in acute coronary syndromes treated with fondaparinux:theFUTURA/OASIS-8 randomized trial 201066.Fifth organization to assess strategies in acute ischemic syndromes investigators;Yusuf S;MehtaSR Comparison of fondaparinux and enoxaparin in acute coronary syndromes 200667.Valgimigli M;Biondi-Zoccai G;Tebaldi M Tirofiban as adjunctive therapy for acute coronarysyndromes and percutaneous coronary intervention:a meta-analysis of randomized trials 201068.Harrington RA;Becker RC;Cannon CP Antithrombotic therapy for non-ST-segment elevation acutecoronary syndromes:American College of Chest Physicians evidence-based clinical practice guidelines(8th edition) 200869.Grines CL;Bonow RO;Casey DE Jr Prevention of premature discontinuation of dual antiplatelettherapy in patients with coronary artery stents:a science advisory from the American HeartAssociation,American College of Cardiology,Society for Cardiovascular Angiography andInterventions,American College of Surgeons,and American Dental Association,with representation fromthe American College of Physicians 200770.Berger JS;Frye CB;Harshaw Q Impact of clopidogrel in patients with acute coronary syndromesrequiring coronary artery bypass surgery:a multicenter analysis 200871.Giugliano RP;White JA;Bode C Early versus delayed,provisional eptifibatide in acute coronarysyndromes 200972.Wiviott S;Braunwald E;McCabe C Prasugrel versus clopidogrel in patients with acute coronarysyndromes 200773.Wallentin L;Becker RC;Budaj A Ticagrelor versus clopidogrel in patients with acute coronarysyndromes 200974.Bhatt DL;Cryer BL;Contant CF Clopidogrel with or without omeprazole in coronary artery disease201075.Antithrombotic trialists (ATT) collaboration;Baigent C;Blackwell L Aspirin in the primary andsecondary prevention of vascular disease:collaborative meta-analysis of individual participant datafrom randomized trials 200976.IONA study group Effect of nicorandil on coronary events in patients with stable angina:theimpact of nicorandil in angina (IONA) randomized trial 200277.Dagenais GR;Pogue J;Fox K Angiotensin-converting-enzyme inhibitors in stable vascular diseasewithout left ventricular systolic dysfunction or heart failure:a combined analysis of three trials200678.中华医学会心血管病学分会;中华心血管病杂志编辑委员会 肾上腺素能受体阻滞剂在心血管疾病应用专家共识 200979.Miller CD;Roe MT;Mulgund J Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction 200780.Wright RS;Anderson JL;Adams CD 2011 ACCF/AHA focused update of the Guidelines for the managementof patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007guideline):a report of the American College of Cardiology Foundation/American Heart Association taskforce on practice guidelines developed in collaboration with the American College of EmergencyPhysicians,Society for Cardiovascular Angio 201181.Kastrati A;Mehilli J;Neumann FJ Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment:the ISAR-REACT 2 randomized trial200682.Breet N;van Werkum J;Bouman H Comparison of platelet function tests in predicting clinicaloutcome in patients undergoing coronary stent implantation 201083.Mega JL;Close SL;Wiviott SD Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomesafter treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial:a pharmacogeneticanalysis 201084.CURRENT-OASIS 7 Investigators;Mehta SR;Bassand JP Dose comparisons of clopidogrel and aspirin inacute coronary syndromes 201085.Granger CB;Goldberg RJ;Dabbous O Predictors of hospital mortality in the global registry of acutecoronary events 200386.Bonaca MP;Wiviott SD;Braunwald E American College of Cardiology/American HeartAssociation/European Society of Cardiology/World